These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Habal FM; Greenberg GR Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391 [TBL] [Abstract][Full Text] [Related]
3. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Andreoli A; Spinella S; Levenstein S; Prantera C Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759 [TBL] [Abstract][Full Text] [Related]
4. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Cohen RD; Woseth DM; Thisted RA; Hanauer SB Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338 [TBL] [Abstract][Full Text] [Related]
5. 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial. D'Arienzo A; Panarese A; D'Armiento FP; Lancia C; Quattrone P; Giannattasio F; Boscaino A; Mazzacca G Am J Gastroenterol; 1990 Sep; 85(9):1079-82. PubMed ID: 2202199 [TBL] [Abstract][Full Text] [Related]
6. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group. Rutgeerts P Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483 [TBL] [Abstract][Full Text] [Related]
8. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon. Frühmorgen P; Demling L Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627 [TBL] [Abstract][Full Text] [Related]
9. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis. Mantzaris GJ; Hatzis A; Petraki K; Spiliadi C; Triantaphyllou G Dis Colon Rectum; 1994 Jan; 37(1):58-62. PubMed ID: 8287749 [TBL] [Abstract][Full Text] [Related]
10. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559 [TBL] [Abstract][Full Text] [Related]
11. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies. Bosworth BP; Sandborn WJ; Rubin DT; Harper JR Inflamm Bowel Dis; 2016 Aug; 22(8):1881-6. PubMed ID: 27416045 [TBL] [Abstract][Full Text] [Related]
12. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission. Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895 [No Abstract] [Full Text] [Related]
13. Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis. Hanauer S; Good LI; Goodman MW; Pizinger RJ; Strum WB; Lyss C; Haber G; Williams CN; Robinson M Am J Gastroenterol; 2000 Jul; 95(7):1749-54. PubMed ID: 10925979 [TBL] [Abstract][Full Text] [Related]
14. Topical salicylate therapy (4-ASA and 5-ASA enemas). Ginsberg AL Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis. Yen EF; Kane SV; Ladabaum U Am J Gastroenterol; 2008 Dec; 103(12):3094-105. PubMed ID: 18775007 [TBL] [Abstract][Full Text] [Related]
16. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA]. Jo Y; Matsumoto T; Iida M Nihon Rinsho; 2005 May; 63(5):820-4. PubMed ID: 15881176 [TBL] [Abstract][Full Text] [Related]
17. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results. Guarino J; Chatzinoff M; Berk T; Friedman LS Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up. Bresci G; Parisi G; Gambardella L; Banti S; Bertoni M; Rindi G; Capria A Int J Clin Pharmacol Res; 1997; 17(1):17-22. PubMed ID: 9403349 [TBL] [Abstract][Full Text] [Related]
19. [5-aminosalicylic acid enema (Pentasa) versus hydrocortisone acetate foam (Proctocort) for the treatment of outbreaks of proctitis and cryptogenetic proctosigmoiditis. A comparative randomized multicenter trial]. Ngô Y; Rambaud JC Gastroenterol Clin Biol; 1992; 16(6-7):558-63. PubMed ID: 1526418 [TBL] [Abstract][Full Text] [Related]
20. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Marshall JK; Irvine EJ Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]